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Viscum album L. lipophilic extract (VALE) contains pharmacologically active pentacyclic triterpenes that are known to exhibit
immunomodulatory, antitumor, and wound healing activity. Preliminary clinical observations indicate that VALE was able to
influence cutaneous wound healing in vivo. The objective of this study was to investigate wound closure related properties of VALE
in vitro. As measured in a wound healing assay, VALE and its predominant triterpene oleanolic acid (OA) significantly and dose
dependently promoted the migration of NIH/3T3 fibroblasts in vitro, thereby leading to an enhanced wound closure. Compared
to the negative control, maximal stimulation by 26.1% and 26.2%, respectively, was attained with 10𝜇g/mL VALE and 1 𝜇g/mL OA.
Stimulation of proliferation in NIH/3T3 fibroblasts by VALE and OA could be excluded. At higher concentrations both substances
affected proliferation and viability of NIH/3T3 fibroblasts and HaCat keratinocytes. In the toxic range of concentrations of VALE
and OA, migration of NIH/3T3 fibroblasts was suppressed. The extent of the stimulatory effect on cell migration of VALE quite
closely corresponded to the effect expected by the concentrations of OA contained in the crude extract VALE. These data support
the casual observation that Viscum album L. lipophilic extract might modulate wound healing related processes in vivo.
1. Introduction
Pentacyclic triterpenes like OA, betulinic acid, and ursolic
acid are lipophilic compounds of mistletoe with promis-
ing pharmacological activities [1–3]. Several properties are
described for OA and betulinic acid including antitu-
mor [4–6], anti-inflammatory [7], anti-HIV [8, 9], and
immunomodulatory activities [10]. Additionally they exert
remarkable wound healing properties [11] and it has been
shown that plant extracts containing pentacyclic triterpenes
are effective in the topical treatment of actinic keratosis [12].
In a prospective case series study, Kunz et al. [13] used an
ointment containing Viscum album lipophilic extract (VALE
unguentum) for the topical treatment of basal cell carcinoma
(BCC). Their clinical findings include promotion of wound
healing and antitumoral properties of the lipophilic mistletoe
extract. A primary hemostatic effect of the treatment followed
by wound closure and partial or complete remission of BCC
was observed.
Cutaneous wound healing is a complex self-limiting
process characterized by a well coordinated, progressive
sequence of events and is structured with regard to both time
and space [14]. The acute wound healing process proceeds
in three partly overlapping phases: hemostasis and inflam-
mation, granulation tissue formation and reepithelialization,
and wound remodeling, and many different cell types are
2 Evidence-Based Complementary and Alternative Medicine
involved, for example, fibroblasts and keratinocytes [15, 16].
As fibroblasts are responsible for initiating angiogenesis,
epithelialization, collagen formation, and synthesis of extra-
cellular matrix proteins [15, 17] an important step of the
second phase consists in activation of fibroblast migration
into the wounded area.
In our study we used a well-established in vitro assay to
mimic the migration of mouse NIH/3T3 fibroblasts to an
artificial wound with the objective to evaluate the pharma-
cological effects of VALE and OA on wound healing and we
tested their effects on viability and proliferation of fibroblasts
and keratinocytes.
2. Material and Methods
2.1. Cell Lines and Cell Culture Conditions. NIH/3T3 mouse
fibroblasts (ATCC, Rockville, MD, USA) were cultured in
RPMI-1640 medium supplemented with 5% heat-inactivated
fetal calf serum (FCS), 2mML-Glutamine, and 1% penicillin-
streptomycin. HaCat human adult keratinocytes (Institute
of Pathology, University Hospital Basel, Switzerland) were
cultured in Dulbecco’s Modified Eagle’s medium (DMEM
low glucose) supplemented with 10% heat-inactivated FCS,
2mM L-Glutamine, and 1% penicillin-streptomycin at 37∘C
in a humidified atmosphere containing 5% CO
2
. For
the experiments, cells were collected from subconfluent
monolayers using trypsin/EDTA and further cultured in
medium containing 1% FCS. All cell culture reagents were
obtained from Sigma (Buchs, Switzerland).
2.2. Reagents andExtracts. Oleanolic acid (OA, purity> 98%)
and dimethyl sulfoxide (DMSO) were purchased from MP
Biomedicals Europe and from Sigma (Buchs, Switzerland),
respectively. Viscum album L. lipophilic extract (VALE),
containing 10% of OA, was obtained by ultracritical CO
2
extraction andwas kindly provided byHiscia Institute, Verein
fu¨r Krebsforschung Arlesheim, Switzerland. OA and VALE
were dissolved in DMSO. Final concentrations of DMSO in
all cell culture assays never surpassed the concentration of 1%.
2.3. WST-1 Cell Viability Assay. The viability of NIH/3T3
and HaCat cells was measured by the use of a colorimetric
WST-1 assay based on the cleavage of the tetrazolium salt
WST-1 by viable cells, according to the supplier’s instructions
(Roche Diagnostica, Rotkreuz, Switzerland). In brief, cells
were seeded into 96-well microtiter plates at a density of
2.5–5 × 103cells per well. NIH/3T3 cells were treated with
either VALE (25–2000𝜇g/mL) or OA (6.13–100𝜇g/mL) for
24 h and 48 h and HaCat cells were treated with either VALE
(100–1600𝜇g/mL) or OA (1.25–80 𝜇g/mL) for 24 h and 48 h,
followed by incubation with WST-1 for 4 h. Absorbance
at 450 nm and 650 nm against a background control was
measured in a multi-well plate reader (Labsystems Multiscan
RC,Helsinki, Finland).The effect of vehicleDMSOon the cell
viability was tested in parallel.
Three independent experiments performed in triplicates
were evaluated. Cell growth inhibition was calculated as
follows: inhibition in % = 100 − (absorbance of treated
cells/absorbance of untreated control ∗ 100).
2.4. In Vitro Wound Healing Assay. The effect of VALE and
OA on wound closure was investigated using a CytoSelect
24-well wound healing assay (Cell Biolabs, Inc., San Diego,
USA).
3 × 10
4 NIH/3T3 fibroblasts in DMEM (1% FCS) were
seeded into the inserts of a CytoSelect 24-well plate and
cultured overnight to allow adhering and reaching a 60–
80% confluence. The inserts were carefully removed, leaving
a defined and precise 0.9mm wound field. The medium was
aspirated and cells were further incubated for 24 h with either
VALE (0.1–2000𝜇g/mL) or oleanolic acid (0.1–50 𝜇g/mL)
in DMEM medium supplemented with 1% FCS. For the
determination of cell migration to the wound field, cells were
stained according to manufacturer’s instructions.
To define confluent area (100%), NIH/3T3 cells were
seeded into wells without created wounded area, allowed
adhering and reaching confluence for 24 h, and subsequently
stained.
DMEM with 5% FCS was used as positive control and
medium with 1% FCS as negative control.
For visualization microscopic images focused on the
center of the wound were photographed and analyzed using
CellD imaging software [18]. The wound healing assay was
repeated 7 times.
For the statistical analysis, all data were standardized to
the density of confluent cells (100%) and expressed as per-
centage of cells in wounded area (%) = (test compound/con-
fluent area) × 100.
2.5. BrdU Proliferation Assay. Cell proliferation was evalu-
ated by 5-bromo-2-deoxyuridine (BrdU) incorporation using
a colorimetric BrdUCell Proliferation ELISA (Roche Applied
Science, Indianapolis, IN, USA) according to manufacturer’s
instructions. Briefly, NIH/3T3 cells were seeded at a density
of 5 × 103/well into a 96-well microtiter plate and allowed
to adhere for 4–6 h in DMEM medium supplemented with
1% FCS. Then cells were cultured in DMEM in the presence
of VALE (0.01–100𝜇g/mL) or OA (0.001–10𝜇g/mL) or in
the absence of tested compounds for 24 h and 48 h. During
the final 24 h of culture, 10 𝜇M BrdU was added. After
DNA denaturation and incubation with anti-BrdU-POD
antibody the absorbance at 450/690 nm was measured using
a multiwell plate reader. Wells with unlabelled cells were set
as background control and wells with culture medium alone
were set as blank.Three independent experiments performed
in triplicates were evaluated.
2.6. Statistics. Viability data from the WST-1 test were
assessed with descriptive statistics (calculation of mean
and standard error (SE)). Data of the wound healing and
proliferation assays were analyzed with analysis of variance
(ANOVA) using the software Statistica 4.0 (Statsoft, Tulsa,
USA). Global significance was assessed with the 𝐹-test. Only
if the preceding 𝐹-test was significant pairwise comparisons
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Figure 1: Dose-dependent cytotoxic effect of VALE on (a) NIH/3T3 and (b) HaCat cells and of OA on (c) NIH/3T3 and (d) HaCat cells after
24 h and 48 h of incubation. Mean values ± SE of three experiments are expressed in percentage of cell viability compared to the untreated
control.
with the LSD-test was carried out (protected Fisher’s LSD-
test).𝑃 values less than 0.05 were considered to be statistically
significant.
3. Results
3.1. Effects of VALE and OA on Cell Viability. As cytotoxic
effects can influence results of the functional wound healing
assay, the effect of VALE and OA on cell viability after 24 h
and 48 h treatment was measured by determining metabolic
activity using the WST-1 assay.
VALE investigated at concentrations from 25 to
2000𝜇g/mL in NIH/3T3 cells and from 100 to 1600 𝜇g/mL
in HaCat cells decreased the viability of both cell lines in a
dose-dependent manner (Figures 1(a) and 1(b)). NIH/3T3
cells were slightly more sensitive to VALE than HaCat cells.
OA displayed a steep dose-dependent cytotoxic effect
on both NIH/3T3 and HaCat cells within a small dose
range (Figures 1(c) and 1(d)). Both cell lines exhibited an
almost complete abrogation of cell viability by concentrations
between 18 and 100 𝜇g/mL OA after 48 h of treatment. Con-
centrations ofVALE< 100 𝜇g/mL andOA< 12.5 𝜇g/mLwere
nontoxic for NIH/3T3 fibroblasts, and VALE < 200 𝜇g/mL
and OA < 10 𝜇g/mL were nontoxic for HaCat keratinocytes
(cell viability > 90%).
The amount of DMSO contained in the tested samples
was used as control to determine the effect of DMSO on
untreated cells. No toxic effect was observed below 1%DMSO
(data not shown).
3.2. Effect of VALE and OA on Migratory Activity and Cell
Growth of NIH/3T3 Fibroblasts. The effect of VALE and
OA on the migratory activity of NIH/3T3 fibroblasts was
evaluated using a wound healing assay. Results are expressed
as percentage of cells in wounded area (Figure 2(a)). 36.9%
of NIH/3T3 positive control cells (5% FCS) migrated to
the wounded area in contrast with 13.5% in the untreated
negative control (1% FCS). Compared to the negative control,
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Figure 2: (a) Effect of VALE and OA on wound closure of NIH/3T3 fibroblasts expressed in % of cells migrated to the wounded area. As
positive control DMEM with 5% FCS and as negative control untreated samples (1% FCS) were used. Density of confluent cells without
created wound was set as 100% wound closure. (b), (c) Effect of VALE and OA on the proliferation of NIH/3T3 fibroblasts was expressed as
proliferation of cells compared to the untreated control. Results are expressed asmeans± SE of 7 independent wound healing or 3 proliferation
experiments, respectively. Significance levels are given compared to the negative control (∗𝑃 < 0.05, ∗∗𝑃 < 0.01, ∗∗∗𝑃 < 0.001, LSD-test).
VALE at concentrations between 0.1 and 10 𝜇g/mL and OA
at concentrations of 0.1 𝜇g/mL and 1.0 𝜇g/mL significantly
promoted the migration of NIH/3T3 cells thereby leading to
an enhanced wound closure. VALE at concentrations from
500 to 2000𝜇g/mL and 50𝜇g/mL of OA significantly inhib-
ited the wound closure (Figure 2(a)). Maximal stimulation
of NIH/3T3 cell migration by VALE and OA was found at
concentrations of 10𝜇g/mL (26.1%, 𝑃 < 0.001) and 1 𝜇g/mL
(26.2%, 𝑃 < 0.001), respectively. The dose-dependent wound
healing effect of VALE and OA is illustrated in Figure 3
showing different extents of wound closure in the original
microphotographs of one representative experiment.
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(a) Confluent cells
(b) Pos. control, 5% FCS, 31.5% migra-
tion
(c) Neg. control, 1% FCS, 10.0% migra-
tion
(d) VALE 1𝜇g/mL, 20.4% migration
(e) VALE 10𝜇g/mL, 29.5% migration
(f) VALE 100𝜇g/mL, 18.6% migration
(g) VALE 1000 𝜇g/mL, 2.5% migration
(h) OA 0.1 𝜇g/mL, 17.9% migration
(i) OA 1𝜇g/mL, 37.1% migration
(j) OA 10𝜇g/mL, 8.2% migration
(k) OA 100𝜇g/mL, 0.5% migration
Figure 3: Representative microphotographs of one experiment, illustrating the dose-dependent effect of VALE (d)–(g) and OA (h)–(k)
on NIH/3T3 fibroblast migration 24 h after monolayer wounding. Data were standardized to the density of confluent cells (100%) (a) and
expressed as percentage of cells in wounded area (% migration) = (test compound/confluent area) × 100. Samples treated with 5% FCS were
set as positive control (b) and untreated samples (1% FCS) were set as negative control (c).
The proliferative response of NIH/3T3 cells on VALE and
OA was assessed by quantitative analysis of the percentage
of cells staining positive for BrdU incorporation. The levels
of proliferation found in response to VALE and OA were
compared to those of the untreated control (1% FCS).
No proliferation stimulating effect could be found with
both substances for the cells at any concentration (Figures
2(b) and 2(c)). A strong and statistically significant inhibition
of proliferation by about 80% was found with OA at a
concentration of 10𝜇g/mL.
4. Discussion
An important finding of our in vitro studywas the stimulatory
effect of VALE and OA on the migratory activity of NIH/3T3
fibroblasts leading to an enhanced wound closure. This effect
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resulted from stimulation of fibroblasts motility rather than
from their mitosis.
Several in vivo studies show wound healing activities of
triterpenes. Metelmann et al. reported remarkable advantage
in promoting wound healing in superficial wounds treated
with triterpenes compared to a moist wound dressing [11].
Severe necrotizing herpes zoster of an immunosuppressed
patient was successfully treated with an emulsion of the
pentacyclic triterpene betulinwithout causing any side effects
[19]. Oleanolic acid isolated from Anredera diffusa induced
an enhanced wound healing activity in mice [20]. In experi-
mental animal models the activity of the triterpene glycoside
asiaticoside, isolated from Centella asiatica, improved and
facilitated normal as well as delayed-type wound healing
and related properties like increase in hydroxyproline, tensile
strength, and collagen content and promoted epithelializa-
tion and angiogenesis [21]. Kunz et al. [13] observed in
a prospective case series study wound healing promoting
and anti-tumoral effects by topical treatment of BCC with
VALE unguentum and more specifically an achievement of
hemostasis in bleeding tumor wounds and after a prolonged
treatment period a wound reepithelialization with a thin
epithelial layer (personal communication).
In the present studywe investigated the effect of lipophilic
mistletoe extract on cutaneous wound healing in vitro.
NIH/3T3 fibroblast cell cultures have been widely used as
a model for testing wound healing activity in vitro [22,
23] because cell migration, proliferation, and collagen pro-
duction of fibroblasts play an essential role in cutaneous
wound healing. Since growth inhibiting and apoptosis-
inducing properties of lipophilic extract from Viscum album
L. and of its predominant triterpene oleanolic acid have
been demonstrated [2], initially the determination of the
nontoxic range of VALE and OA was crucial to choose
appropriate concentrations when performing the functional
wound healing assay. Cell survival was estimated after 24 h
and 48 h of treatment using the WST-1 assay. Cells with a
viability > 90% of the untreated control were considered to
be unaffected. Our results demonstrated that concentrations
of VALE < 100𝜇g/mL and of OA < 12.5 𝜇g/mL were nontoxic
for NIH/3T3 fibroblasts. HaCat keratinocytes were slightly
less sensitive and concentrations of VALE < 200𝜇g/mL and
of OA < 10 𝜇g/mL were revealed to be nontoxic for this
cell type. We thus observed a comparable effect of VALE
and OA on the viability of fibroblasts and keratinocytes,
cell types whose proliferation, migration, and complex
interactions play a primary role in wound healing [24].
Parallel experiments revealed similar dose response curves
for NIH/3T3 cell viability after treatment with betulinic
acid with nontoxic concentrations <2.5–5.0 𝜇g/mL (data not
shown).
Fibroblast migration is one of the essential steps during
the proliferative phase of wound healing and during wound
closure. The effect of VALE and OA on the migration of
NIH/3T3 fibroblasts was investigated using the CytoSelect
24-well wound healing assay. Former experiments performed
under similar cell culture and assay conditions illustrate
the reliability of the assay to study the influence of wound
healing compounds like Bepanthen Plus (Bayer Schweiz AG)
on NIH/3T3 fibroblast migration (see supplementary mate-
rial available online at http://dx.doi.org/10.1155/2013/718105).
We observed a dose-dependent stimulation of migration at
nontoxic doses of VALE (0.1–10 𝜇g/mL) and of OA (0.1–
1 𝜇g/mL) and an inhibition of migration at higher doses
of VALE (500–2000𝜇g/mL) and of OA (50𝜇g/mL). This
inhibitory effect on fibroblast migration corresponds to our
results of the cytotoxic properties of VALE and OA in
NIH/3T3 fibroblasts. With a proportion of 10%, OA is the
most prominent triterpene found in VALE. The strongest
stimulation of migration was found with 10𝜇g/mL of VALE
and its corresponding concentration of 1𝜇g/mL of OA. For
this reason we hypothesize that the main active component
in VALE responsible for the stimulatory effect on NIH/3T3
fibroblast migration was OA.
Cell migration is not the only component which con-
tributes to wound closure. Cell proliferation has also to be
taken into account. We investigated a possible induction of
NIH/3T3 fibroblast proliferation by VALE and OA as the
wound healing assay used does not allow a clear distinction
between migration and proliferation.The results of the BrdU
incorporation assay revealed no mitogenic effect of VALE
and OA on NIH/3T3 fibroblasts under the experimental
conditions used. Enhanced NIH/3T3 cell numbers in an
artificial wound by triterpene containing birch bark extract
as well as isolated triterpenes in a concentration-dependent
manner were also reported by Naumann et al. [25]. In their
study, fibroblast proliferation as well as cell migration was
influenced. Additionally, HaCat cells treated with the birch
bark extract revealed a time-dependent increase of COX-2
mRNA, the key enzyme for the prostaglandin E2 production.
Cells use different signaling pathways for migration from
those for proliferation. For example, migratory effects of
members of heparin-binding fibroblast growth factor family
(FGFs) are clearly discriminated from proliferative effects
[26].Themechanisms and signaling pathways responsible for
the migratory effect of VALE and OA onNIH/3T3 fibroblasts
are unclear at present and need further investigation.
5. Conclusions
Clinical observations indicate a relevant contribution of
Viscum album lipophilic extract (VALE) to wound healing
in vivo, thus highlighting the therapeutic potential of the
lipophilic fraction of mistletoe. Our in vitro results demon-
strate that VALE and oleanolic acid stimulated the migration
of NIH/3T3 fibroblasts in vitro, which led to an enhanced
wound closure. These findings are a first step in the process
of investigating the underlying mechanisms of the effects of
VALE on wound healing.
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